Drugs

Despite the hype surrounding GLP-1 receptor agonists, a significant proportion of patients discontinue treatment after a few months, reducing the chances of long-term benefits.

There are evidence-based ways to make a difference for patients.

Get the info you need on this new product, part of our drug news roundup for October.

Up to 31% of patients with Hyperemesis Gravidarum stop meds because of side effects.

Study participants who were treated with the GLP-1 inhibitor had a lower risk of dementia, ischemic stroke and all-cause mortality.

Get the info you need on these new dosage forms, part of our drug news roundup for October.

The primary goals in the treatment of pediatric fever should be to improve the patient’s overall comfort, maintain hydration and address signs of serious illness.

Pharmacists can play key roles in monitoring adherence and treatment response, and managing adverse effects.